دواء لمرض علزهايمر وائدة واعدة في تحسين على التحدة التوحد

A recent study showed that the drug “ميمانتين”, originally designed to treat Alzheimer’s disease, can help improve communication skills على التعليقة على التعليقين بلتوحد, ما يفتح عفاقً جديدة للعلاج الدوائي للتوحدة التوزراب.

The experiment was carried out in Massachusetts General Hospital in Boston, and 42 teenagers aged 13 years and older participated in it, to evaluate the effect “ميمانتين” المعروف عابًا بسم “إبيكسا” على على التحميل التوحد. The drug works by blocking the effect of glutamate in the brain, which is an important neurotransmitter, usually used to treat Alzheimer’s disease. It doesn’t respond to conventional treatments, according to the Daily Mail website

After 12 weeks of treatment, the researchers noticed that more than half of the participants who ate “ميمانتين” showed significant improvement in social communication skills, compared to only 20% of the group that took fake medicine, as it shows the probability of response للعلاج was higher than 4.8 times for the teenagers who ate the drug.

The study indicated that the drug was more effective in teenagers who have high levels of glutamate, which يُتعدد أن لها دورً في ذاهور بسعة التحميل التوحد مزل فيحة على تعليقة و حرت للصفحة للسواء والالم.

The researchers confirmed that the results indicate that “ميمانتين” may be a treatment option for a large part of the disease, with the necessity Conduct further experimental studies to confirm these results and expand the scope to include various categories of patients.

Except that the study had some limitations, as it included the majority of white participants and did not include adolescents with autism and mental disabilities. It does not affect the possibility of generalizing the results to all categories.